Last updated on October 2017

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women


Brief description of study

The purpose of this study is to assess the efficacy and safety of MT-8554 for treatment of vasomotor symptoms (VMS) associated with menopause.

Detailed Study Description

This is a Phase II randomized, double-blind, placebo-controlled study for dose selection in postmenopausal women with moderate to severe VMS, defined as follows: - Moderate: sensation of heat with sweating, able to continue activity - Severe: sensation of heat with sweating, causing cessation of activity This study is comprised of a screening period, a run-in period and a 12-week double-blind treatment period.

Clinical Study Identifier: NCT03291067

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Clinical Trials Information Desk, to ...

Research Site
Phoenix, AZ United States
  Connect »

Clinical Trials Information Desk, to ...

Research Site
Clearwater, FL United States
  Connect »

Clinical Trials Information Desk, to ...

Research Site
Jupiter, FL United States
  Connect »

Clinical Trials Information Desk, to ...

Research Site
Kansas City, MO United States
  Connect »

Clinical Trials Information Desk, to ...

Research Site
Schertz, TX United States
  Connect »